PriceTargets.com logo

Global Medical REIT - GMRE Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $11.25
  • Forecasted Upside: 28.73%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$8.74 As of 03/28/2025 04:59 PM ET
▲ +0.049 (0.56%)

This chart shows the closing price for GMRE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
FebMar$8.74Closing price on 03/29/25:
Get New Global Medical REIT Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GMRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GMRE

Analyst Price Target is $11.25
▲ +28.73% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Global Medical REIT in the last 3 months. The average price target is $11.25, with a high forecast of $12.00 and a low forecast of $10.00. The average price target represents a 28.73% upside from the last price of $8.74.

This chart shows the closing price for GMRE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
3/246/249/2412/243/254/26$5.26$6.95$8.63$10$12Closing price on 03/29/25: $8.74High$12.00Average$11.25Low$10.00




Current Consensus is Buy

The current consensus among 3 investment analysts is to buy stock in Global Medical REIT. This rating has held steady since October 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
10/6/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/4/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/3/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/2/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/30/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/29/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/27/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/29/2025

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/18/2024Berenberg BankInitiated CoverageBuy$11.75
9/19/2024Alliance Global PartnersInitiated CoverageBuy$12.00
5/13/2024B. RileyLower TargetBuy ➝ Buy$11.00 ➝ $10.00
8/4/2023Compass PointBoost Target$11.00 ➝ $12.50
5/8/2023B. RileyLower Target$12.00 ➝ $11.00
5/4/2023Stifel NicolausLower Target$13.00 ➝ $11.00
3/6/2023B. RileyLower TargetBuy$14.00 ➝ $12.00
10/10/2022Robert W. BairdDowngradeOutperform ➝ Neutral
10/6/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform
8/15/2022Compass PointLower Target$17.00
8/9/2022Compass PointLower Target$17.00
7/7/2022JMP SecuritiesInitiated CoverageMarket Perform
5/10/2022B. RileyLower Target$18.00 ➝ $16.00
3/2/2022B. RileyLower Target$20.00 ➝ $18.00
9/20/2021KeyCorpInitiated CoverageOverweight$17.00
7/9/2021Colliers SecuritiesInitiated CoverageBuy$18.00
6/15/2021B. RileyBoost TargetBuy$16.00 ➝ $18.00
4/16/2021BMO Capital MarketsInitiated CoverageOutperform$16.00
9/1/2020Stifel NicolausReiterated RatingBuy$15.00
7/1/2020Berenberg BankInitiated CoverageBuy$13.00
(Data available from 3/29/2020 forward)

News Sentiment Rating

0.54 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2024
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2024
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2024
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/29/2024
  • 3 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
12/29/2024
  • 7 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/28/2025
  • 4 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/27/2025
  • 6 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/29/2025

Current Sentiment

  • 6 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Global Medical REIT logo
Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Read More

Today's Range

Now: $8.74
Low: $8.60
High: $8.75

50 Day Range

MA: $8.36
Low: $7.84
High: $9.08

52 Week Range

Now: $8.74
Low: $7.33
High: $10.46

Volume

259,328 shs

Average Volume

423,982 shs

Market Capitalization

$584.39 million

P/E Ratio

N/A

Dividend Yield

9.91%

Beta

1.26

Frequently Asked Questions

What sell-side analysts currently cover shares of Global Medical REIT?

The following equities research analysts have issued stock ratings on Global Medical REIT in the last year: Alliance Global Partners, B. Riley, and Berenberg Bank.
View the latest analyst ratings for GMRE.

What is the current price target for Global Medical REIT?

0 Wall Street analysts have set twelve-month price targets for Global Medical REIT in the last year. Their average twelve-month price target is $11.25, suggesting a possible upside of 28.7%. Alliance Global Partners has the highest price target set, predicting GMRE will reach $12.00 in the next twelve months. B. Riley has the lowest price target set, forecasting a price of $10.00 for Global Medical REIT in the next year.
View the latest price targets for GMRE.

What is the current consensus analyst rating for Global Medical REIT?

Global Medical REIT currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GMRE will outperform the market and that investors should add to their positions of Global Medical REIT.
View the latest ratings for GMRE.

What other companies compete with Global Medical REIT?

Other companies that are similar to Global Medical REIT include SSR Mining, Global Net Lease, DigitalBridge Group, UP Fintech and Veris Residential. Learn More about companies similar to Global Medical REIT.

How do I contact Global Medical REIT's investor relations team?

Global Medical REIT's physical mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company's listed phone number is (202) 524-6851 and its investor relations email address is investors@globalmedicalreit.com. The official website for Global Medical REIT is www.globalmedicalreit.com. Learn More about contacing Global Medical REIT investor relations.





Receive Global Medical REIT News & Ratings Daily
Sign up to receive the latest news and ratings for Global Medical REIT and its competitors with PriceTargets.com’s free daily newsletter.